Skip to main content

Table 1 Baseline characteristics

From: Apolipoprotein CIII predicts cardiovascular events in patients with coronary artery disease: a prospective observational study

 

All

No event

Event

P value

General

 N =

195

103

92

 Age in years

66.9 (10.2)

66.3 (11.0)

67.7 (9.2)

0.358

 Male

87.2 (170)

88.3 (91)

85.9 (79)

0.380

 Received OGTT

56.4 (110)

60.2 (62)

52.2 (48)

0.163

Medical History

 Previous myocardial infarction

43.1 (84)

37.9 (39)

48.9 (45)

0.079

 Cardiac bypass surgery

13.8 (27)

9.7 (10)

18.5 (17)

0.059

 Previous stroke or TIA

9.2 (18)

9.7 (10)

8.7 (8)

0.503

 Peripheral artery disease

7.7 (15)

10.7 (11)

4.3 (4)

0.081

Medication

 Platelet inhibitors

96.9 (189)

96.1 (99)

97.8 (90)

0.396

 ACE inhibitors/ARBs

96.4 (188)

95.1 (98)

97.8 (90)

0.271

 Beta blockers

91.8 (179)

88.3 (91)

95.7 (88)

0.054

 Statins

97.4 (190)

98.1 (101)

96.7 (89)

0.447

Clinical characteristics

 Smoking (active)

17.4 (34)

23.3 (24)

10.9 (10)

0.017

 Alcohol regularly

21.0 (41)

22.3 (23)

19.6 (18)

0.384

 Positive family history

34.3 (67)

35.9 (37)

32.6 (30)

0.369

 Hypertension

95.9 (187)

92.2 (95)

100.0 (92)

0.005

 Systolic blood pressure in mmHg

126.1 (15.1)

124.4 (13.8)

128.0 (16.4)

0.095

 Diastolic blood pressure in mmHg

74.6 (8.1)

74.0 (8.1)

75.3 (8.1)

0.246

 Resting heart rate in min−1

66.6 (8.4)

66.8 (8.2)

66.4 (8.8)

0.771

 LV ejection fraction in %

62.3 (12.3)

62.7 (11.9)

61.9 (12.8)

0.664

 Body mass index in kg/m2

28.8 (3.9)

28.4 (4.1)

29.2 (3.6)

0.194

 Waist circumference in cm

103.8 (10.5)

103.0 (10.5)

104.8 (10.4)

0.224

 Waist-to-hip ratio

1.00 (0.06)

1.00 (0.06)

1.01 (0.07)

0.477

Metabolic characterization

 Normal glucose tolerance

29.2 (57)

33.0 (34)

25.0 (23)

0.142

 Impaired glucose tolerance

24.1 (47)

24.3 (25)

23.9 (22)

 

 Diabetes mellitus

46.7 (91)

42.7 (44)

51.1 (47)

 

 Metabolic syndrome

59.5 (116)

51.5 (53)

68.5 (63)

0.011

 Fasting glucose in mg/dL

129.9 (38.2)

128.4 (37.4)

131.7 (39.2)

0.557

 Fasting insulin in μIU/mL

10.7 (9.7)

9.9 (7.8)

11.5 (11.4)

0.238

 HOMA index

3.42 (4.08)

3.04 (3.29)

3.83 (4,81)

0.177

 HbA1c in %

6.0 (1.1)

5.9 (0.8)

6.2 (1.3)

0.063

 Total cholesterol in mg/dL

174.9 (38.4)

173.3 (36.3)

176.6 (40.8)

0.550

 HDL cholesterol in mg/dL

44.9 (13.5)

44.9 (11.3)

45.0 (15.7)

0.970

 LDL cholesterol in mg/dL

106.4 (34.1)

107.0 (33.3)

105.7 (35.2)

0.802

 Non-HDL cholesterol mg/dL

129.9 (138.2)

128.4 (37.4)

131.7 (39.2)

0.557

 Fasting triglycerides in mg/dL

151.1 (95.7)

135.6 (67.5)

168.4 (117.7)

0.016

 Postprandial 5 h-Tg-AUC in mg/dL

1065 (599)

979 (477)

1161 (701)

0.033

 C-reactive protein in mg/dL

4.8 (8.7)

4.6 (7.3)

5.0 (10.1)

0.741

  1. Numerical variables are presented as mean (standard deviation), the other variables are % (n), or as otherwise indicated. OGTT oral glucose tolerance test, TIA transient ischemic attack, ACE angiotensin-converting enzyme, ARB angiotensin II receptor blocker, LV left ventricular, HOMA homeostasis model assessment, Tg triglycerides, AUC area under the curve